Literature DB >> 3515253

The evaluation of the methods used in the diagnosis of intrauterine growth retardation.

J Villar, J M Belizan.   

Abstract

Several methods used in the diagnosis of intrauterine growth retardation (IUGR) were evaluated with epidemiologic techniques. The strong effect of IUGR prevalence on the positive predictive and false-positive values of these methods is discussed. If correctly used, the combination of clinical measurements and perinatal risk factors can have a predictive power as high as any of the other more sophisticated techniques. The data reviewed show that at present biparietal diameter measurements, nonstress test/oxytocin challenge test or hormone values do not contribute to a better IUGR prediction than when the above mentioned methods are applied. For IUGR detection, ultrasound evaluation should include ratios of anthropometric measurements and may be complemented with amniotic fluid volume assessment. It is suggested that these procedures be reserved to a selected high risk population. Efforts should be made to evaluate new technologies through randomized controlled trials before they are introduced to the general population, particularly in developing countries.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515253     DOI: 10.1097/00006254-198604000-00001

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  3 in total

Review 1.  Diagnosis and management of fetal growth retardation.

Authors:  D James
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

2.  The predictive value of plasma fibronectin concentration on fetal growth retardation at earlier stage of the third trimester.

Authors:  Z Wang; G Xiong; Y Zhu
Journal:  J Tongji Med Univ       Date:  2001

3.  Risk factors of stunting among children living in an urban slum of Bangladesh: findings of a prospective cohort study.

Authors:  M Munirul Islam; Kazi Istiaque Sanin; Mustafa Mahfuz; A M Shamsir Ahmed; Dinesh Mondal; Rashidul Haque; Tahmeed Ahmed
Journal:  BMC Public Health       Date:  2018-01-30       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.